-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Prometheus Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q1 2023.
- Prometheus Biosciences, Inc. Operating Income (Loss) for the quarter ending March 31, 2023 was -$48.7M, a 51.7% decline year-over-year.
- Prometheus Biosciences, Inc. Operating Income (Loss) for the twelve months ending March 31, 2023 was -$162M, a 50.8% decline year-over-year.
- Prometheus Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$146M, a 66% decline from 2021.
- Prometheus Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$87.8M, a 203% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)